ATE478840T1 - 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung - Google Patents

3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung

Info

Publication number: ATE478840T1
Authority: AT; Austria
Prior art keywords: derivatives; aminoazetidedine; production; pharmaceutical compositions; compositions containing
Prior art date: 2000-03-03

Application number

AT01909938T

Other languages

English (en)

Inventor

Daniel Achard

Herve Bouchard

Jean Bouquerel

Bruno Filoche

Serge Grisoni

Augustin Hittinger

Michael Myers

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-03

Filing date

2001-03-01

Publication date

2010-09-15

2001-03-01 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2010-09-15 Application granted granted Critical

2010-09-15 Publication of ATE478840T1 publication Critical patent/ATE478840T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Psychology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Child & Adolescent Psychology (AREA)
Rheumatology (AREA)
Nutrition Science (AREA)
Obesity (AREA)
Reproductive Health (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

AT01909938T 2000-03-03 2001-03-01 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung ATE478840T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0002777A FR2805810B1 (fr)	2000-03-03	2000-03-03	Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
PCT/FR2001/000601 WO2001064633A1 (fr)	2000-03-03	2001-03-01	Compositions pharmaceutiques contenant des derives de 3-amino-azetidine, les nouveaux derives et leur preparation

Publications (1)

Publication Number	Publication Date
ATE478840T1 true ATE478840T1 (de)	2010-09-15

Family

ID=8847707

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01909938T ATE478840T1 (de)	2000-03-03	2001-03-01	3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung

Country Status (35)

Country	Link
EP (1)	EP1263721B1 (de)
JP (1)	JP2003525269A (de)
KR (1)	KR100813740B1 (de)
CN (1)	CN1187325C (de)
AR (1)	AR034405A1 (de)
AT (1)	ATE478840T1 (de)
AU (2)	AU2001237526B2 (de)
BG (1)	BG107057A (de)
BR (1)	BR0108894A (de)
CA (1)	CA2400138A1 (de)
CY (1)	CY1111075T1 (de)
DE (1)	DE60142890D1 (de)
DK (1)	DK1263721T3 (de)
DZ (1)	DZ3311A1 (de)
EA (1)	EA004649B1 (de)
EE (1)	EE05081B1 (de)
ES (1)	ES2351183T3 (de)
FR (1)	FR2805810B1 (de)
HR (1)	HRP20020710A2 (de)
HU (1)	HUP0300350A2 (de)
IL (2)	IL151209A0 (de)
MA (1)	MA26879A1 (de)
MX (1)	MXPA02008346A (de)
NO (1)	NO324523B1 (de)
NZ (1)	NZ521076A (de)
OA (1)	OA12221A (de)
PL (1)	PL365007A1 (de)
PT (1)	PT1263721E (de)
SI (1)	SI1263721T1 (de)
SK (1)	SK12442002A3 (de)
TW (1)	TWI294420B (de)
UA (1)	UA72319C2 (de)
WO (1)	WO2001064633A1 (de)
YU (1)	YU65902A (de)
ZA (1)	ZA200206916B (de)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001288972A1 (en)	2000-09-11	2002-03-26	Sepracor, Inc.	Antipsychotic sulfonamide-heterocycles, and methods of use thereof
FR2814678B1 (fr) *	2000-10-04	2002-12-20	Aventis Pharma Sa	Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
WO2003007887A2 (en)	2001-07-20	2003-01-30	Merck & Co., Inc.	Substituted imidazoles as cannabinoid receptor modulators
FR2833842B1 (fr) *	2001-12-21	2004-02-13	Aventis Pharma Sa	Compositions pharmaceutiques a base de derives d'azetidine
US7351729B2 (en)	2002-03-08	2008-04-01	Signal Pharmaceuticals, Llc	JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers
JP3813152B2 (ja)	2002-03-12	2006-08-23	メルクエンドカムパニーインコーポレーテッド	置換アミド類
FR2837706A1 (fr) *	2002-03-28	2003-10-03	Sanofi Synthelabo	Utilisation d'un antagoniste des recepteurs aux cannabinoides cb1 pour la preparation de medicaments utiles pour traiter les dysfonctionnements sexuels et/ou ameliorer les performances sexuelles
US7105526B2 (en)	2002-06-28	2006-09-12	Banyu Pharmaceuticals Co., Ltd.	Benzimidazole derivatives
CA2493313C (en)	2002-07-29	2010-03-09	F. Hoffmann-La Roche Ag	Novel benzodioxoles
EP1583762B1 (de)	2003-01-02	2008-07-09	F. Hoffmann-La Roche Ag	Pyrrolyl-thiazole und ihre verwendung als inverse agonisten des cb 1 rezeptors
RU2339618C2 (ru)	2003-01-02	2008-11-27	Ф.Хоффманн-Ля Рош Аг	Новые обратные агонисты рецептора св1
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
BRPI0409959A (pt) *	2003-05-01	2006-04-25	Vernalis Res Ltd	uso de derivados de azetidinacarboxamida em terapia
RU2006100298A (ru) *	2003-06-11	2006-05-10	Мерк энд Ко., Инк. (US)	Замещенные производные 3-алкил-и 3-алкенилазетидинов
CN100368407C (zh)	2003-06-20	2008-02-13	霍夫曼-拉罗奇有限公司	作为cb1受体反激动剂的2-酰氨基苯并噻唑
ATE547404T1 (de)	2003-09-22	2012-03-15	Msd Kk	Piperidinderivate
ATE384058T1 (de)	2003-12-08	2008-02-15	Hoffmann La Roche	Thiazolderivate
ES2349195T3 (es)	2004-01-28	2010-12-28	F. Hoffmann-La Roche Ag	Espiro-benzodioxoles y su uso como antagonistas de cb1.
KR20060124756A (ko) *	2004-02-17	2006-12-05	라보라토리오스 델 드라. 에스테브.에스.에이.	치환된 아제티딘 화합물, 그 제조 및 약제로써의 용도
EP1574211A1 (de)	2004-03-09	2005-09-14	Inserm	Verwendung von CB1-Rezeptor-Antagonisten zur Herstellung eines Arzneimittels zur Behandlung von Lebererkrankungen
US20080125403A1 (en)	2004-04-02	2008-05-29	Merck & Co., Inc.	Method of Treating Men with Metabolic and Anthropometric Disorders
CA2564986A1 (en)	2004-05-10	2005-11-17	F. Hoffmann-La Roche Ag	Pyrrole or imidazole amides for treating obesity
AU2005298986A1 (en)	2004-10-27	2006-05-04	F. Hoffmann-La Roche Ag	New indole or benzimidazole derivatives
BRPI0517653A (pt)	2004-11-09	2008-10-14	Hoffmann La Roche	compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para o tratamento e/ou profilaxia de enfermidades e utilização dos compostos
PL1868999T3 (pl)	2005-04-06	2009-12-31	Hoffmann La Roche	Pochodne pirydyno-3-karboksyamidu jako odwrotni agoniści CB1
AU2006253312B2 (en)	2005-05-30	2011-08-18	Msd K.K.	Novel piperidine derivative
CA2613678A1 (en)	2005-06-02	2006-12-07	Glenmark Pharmaceuticals S.A.	Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
US7923465B2 (en)	2005-06-02	2011-04-12	Glenmark Pharmaceuticals S.A.	Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
WO2007018248A1 (ja)	2005-08-10	2007-02-15	Banyu Pharmaceutical Co., Ltd.	ピリドン化合物
US8008425B2 (en)	2005-08-18	2011-08-30	Nissan Chemical Industries, Ltd.	Thiophene compound having sulfonyl group and process for producing the same
AU2006282260A1 (en)	2005-08-24	2007-03-01	Msd K.K.	Phenylpyridone derivative
US20090264426A1 (en)	2005-09-07	2009-10-22	Shunji Sakuraba	Bicyclic aromatic substituted pyridone derivative
BRPI0616463A2 (pt)	2005-09-29	2011-06-21	Merck & Co Inc	composto, composição farmacêutica, e, uso de um composto
US8163770B2 (en)	2005-10-27	2012-04-24	Msd. K. K.	Benzoxathiin derivative
US8158791B2 (en)	2005-11-10	2012-04-17	Msd K.K.	Aza-substituted spiro derivatives
AR058199A1 (es) *	2005-11-28	2008-01-23	Merck & Co Inc	Derivados de 3- alquilazetidina sustituidos con heterociclos
US7906652B2 (en)	2005-11-28	2011-03-15	Merck Sharp & Dohme Corp.	Heterocycle-substituted 3-alkyl azetidine derivatives
US7629346B2 (en)	2006-06-19	2009-12-08	Hoffmann-La Roche Inc.	Pyrazinecarboxamide derivatives as CB1 antagonists
KR20090047458A (ko)	2006-08-08	2009-05-12	사노피-아벤티스	아릴아미노아릴-알킬-치환된 이미다졸리딘-2,4-디온, 이의 제조방법, 이들 화합물을 포함하는 약제 및 이의 용도
US7781593B2 (en)	2006-09-14	2010-08-24	Hoffmann-La Roche Inc.	5-phenyl-nicotinamide derivatives
EP2083831B1 (de)	2006-09-22	2013-12-25	Merck Sharp & Dohme Corp.	Verfahren zur behandlung von fettsäure-synthese-hemmern
AU2007301126A1 (en)	2006-09-28	2008-04-03	Banyu Pharmaceutical Co., Ltd.	Diaryl ketimine derivative
CA2682727C (en)	2007-04-02	2016-03-22	Banyu Pharmaceutical Co., Ltd.	Indoledione derivative
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2688161C (en)	2007-06-04	2020-10-20	Kunwar Shailubhai	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009220605A1 (en)	2008-03-06	2009-09-11	Msd K.K.	Alkylaminopyridine derivative
US20110015198A1 (en)	2008-03-28	2011-01-20	Banyu Pharmaceutical Co., Inc.	Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism
ES2522968T3 (es)	2008-06-04	2014-11-19	Synergy Pharmaceuticals Inc.	Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
EP2301936A1 (de)	2008-06-19	2011-03-30	Banyu Pharmaceutical Co., Ltd.	Spirodiamin-diarylketoximid-derivat
WO2010009319A2 (en)	2008-07-16	2010-01-21	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US20110124674A1 (en)	2008-07-30	2011-05-26	Hiroyuki Kishino	5/5-or 5/6-membered condensed ring cycloalkylamine derivative
MX2011004258A (es)	2008-10-22	2011-06-01	Merck Sharp & Dohme	Derivados de bencimidazol ciclicos novedosos utiles como agentes anti-diabeticos.
WO2010051236A1 (en)	2008-10-30	2010-05-06	Merck Sharp & Dohme Corp.	Isonicotinamide orexin receptor antagonists
US8329914B2 (en)	2008-10-31	2012-12-11	Merck Sharp & Dohme Corp	Cyclic benzimidazole derivatives useful as anti-diabetic agents
EP2358200A4 (de)	2008-11-17	2012-05-16	Merck Sharp & Dohme	Substituierte bizyklische amine für die behandlung von diabetes
US20120220567A1 (en)	2009-07-23	2012-08-30	Shipps Jr Gerald W	Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
WO2011011506A1 (en)	2009-07-23	2011-01-27	Schering Corporation	Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
EP2538784B1 (de)	2010-02-25	2015-09-09	Merck Sharp & Dohme Corp.	Benzimidazolderivate als antidiabetika
US8785634B2 (en)	2010-04-26	2014-07-22	Merck Sharp & Dohme Corp	Spiropiperidine prolylcarboxypeptidase inhibitors
EP2568812B1 (de)	2010-05-11	2016-10-26	Merck Sharp & Dohme Corp.	Neuartige prolylcarboxypeptidase-hemmer
EP2579873A4 (de)	2010-06-11	2013-11-27	Merck Sharp & Dohme	Neuartige prolylcarboxypeptidase-hemmer
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
US8410107B2 (en)	2010-10-15	2013-04-02	Hoffmann-La Roche Inc.	N-pyridin-3-yl or N-pyrazin-2-yl carboxamides
WO2012054721A1 (en) *	2010-10-22	2012-04-26	Janssen Pharmaceutical Nv	Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors
US8669254B2 (en)	2010-12-15	2014-03-11	Hoffman-La Roche Inc.	Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents
PE20140859A1 (es)	2011-02-25	2014-07-25	Merck Sharp & Dohme	Novedosos derivados de azabencimidazol ciclico utiles como agentes antidiabeticos
WO2012120058A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120050A1 (de)	2011-03-08	2012-09-13	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683703B1 (de)	2011-03-08	2015-05-27	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8809325B2 (en)	2011-03-08	2014-08-19	Sanofi	Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
AR088352A1 (es)	2011-10-19	2014-05-28	Merck Sharp & Dohme	Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
RU2015106909A (ru)	2012-08-02	2016-09-27	Мерк Шарп И Доум Корп.	Антидиабетические трициклические соединения
US9840512B2 (en)	2013-02-22	2017-12-12	Merck Sharp & Dohme Corp.	Antidiabetic bicyclic compounds
WO2014139388A1 (en)	2013-03-14	2014-09-18	Merck Sharp & Dohme Corp.	Novel indole derivatives useful as anti-diabetic agents
CA2905438A1 (en)	2013-03-15	2014-09-25	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
EP2968439A2 (de)	2013-03-15	2016-01-20	Synergy Pharmaceuticals Inc.	Zusammensetzungen zur behandlung von magen-darm-störungen
KR102272746B1 (ko)	2013-06-05	2021-07-08	보슈 헬스 아일랜드 리미티드	구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
WO2015051496A1 (en)	2013-10-08	2015-04-16	Merck Sharp & Dohme Corp.	Antidiabetic tricyclic compounds
CN107207483B (zh)	2014-08-29	2020-10-30	Tes制药有限责任公司	α-氨基-β-羧基粘康酸半醛脱羧酶抑制剂
MX2019004321A (es)	2016-10-14	2019-06-12	Tes Pharma S R L	Inhibidores de la acido alfa-amino-beta-carboximuconico semialdehido descarboxilasa.
US11072602B2 (en)	2016-12-06	2021-07-27	Merck Sharp & Dohme Corp.	Antidiabetic heterocyclic compounds
TW202033516A (zh)	2018-11-20	2020-09-16	義大利商Ｔｅｓ製藥（股份）責任有限公司	α-胺基-β-羧基己二烯二酸半醛去羧酶之抑制劑
WO2020167706A1 (en)	2019-02-13	2020-08-20	Merck Sharp & Dohme Corp.	5-alkyl pyrrolidine orexin receptor agonists
EP4010314B1 (de)	2019-08-08	2024-02-28	Merck Sharp & Dohme LLC	Heteroaryl-pyrrolidin- und piperidinorexinrezeptor-agonisten
IL300610A (en)	2020-08-18	2023-04-01	Merck Sharp ַ& Dohme Llc	Bicycloheptane pyrrolidine compounds are orexin receptor agonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4242261A (en) *	1979-07-19	1980-12-30	A. H. Robins Company, Inc.	Production of methylene-cycloamines
FR2649100B1 (fr) *	1989-06-29	1994-03-04	Laboratorios Dr Esteve Sa	Nouvelles azetidines, leur preparation et leur application comme intermediaires pour la preparation de composes avec activite antimicrobienne
JPH05201971A (ja) *	1992-01-28	1993-08-10	Hokuriku Seiyaku Co Ltd	環状アミン含有ベンゼンスルホンアミド誘導体
JPH11508540A (ja) *	1995-06-29	1999-07-27	ノボノルディスクアクティーゼルスカブ	新規の置換アザ環式またはアザ二環式化合物
GB9714129D0 (en) *	1997-07-04	1997-09-10	Pfizer Ltd	Azetidines

2000
- 2000-03-03 FR FR0002777A patent/FR2805810B1/fr not_active Expired - Fee Related
2001
- 2001-01-03 UA UA2002097700A patent/UA72319C2/uk unknown
- 2001-02-23 TW TW090104188A patent/TWI294420B/zh not_active IP Right Cessation
- 2001-03-01 SK SK1244-2002A patent/SK12442002A3/sk unknown
- 2001-03-01 EP EP01909938A patent/EP1263721B1/de not_active Expired - Lifetime
- 2001-03-01 YU YU65902A patent/YU65902A/sh unknown
- 2001-03-01 MX MXPA02008346A patent/MXPA02008346A/es active IP Right Grant
- 2001-03-01 AU AU2001237526A patent/AU2001237526B2/en not_active Ceased
- 2001-03-01 NZ NZ521076A patent/NZ521076A/en unknown
- 2001-03-01 PL PL01365007A patent/PL365007A1/xx not_active IP Right Cessation
- 2001-03-01 SI SI200130980T patent/SI1263721T1/sl unknown
- 2001-03-01 PT PT01909938T patent/PT1263721E/pt unknown
- 2001-03-01 AU AU3752601A patent/AU3752601A/xx active Pending
- 2001-03-01 CN CNB018060269A patent/CN1187325C/zh not_active Expired - Fee Related
- 2001-03-01 KR KR1020027011516A patent/KR100813740B1/ko not_active IP Right Cessation
- 2001-03-01 ES ES01909938T patent/ES2351183T3/es not_active Expired - Lifetime
- 2001-03-01 IL IL15120901A patent/IL151209A0/xx unknown
- 2001-03-01 BR BR0108894-7A patent/BR0108894A/pt not_active Application Discontinuation
- 2001-03-01 HU HU0300350A patent/HUP0300350A2/hu unknown
- 2001-03-01 EA EA200200942A patent/EA004649B1/ru not_active IP Right Cessation
- 2001-03-01 JP JP2001563476A patent/JP2003525269A/ja not_active Ceased
- 2001-03-01 AT AT01909938T patent/ATE478840T1/de active
- 2001-03-01 CA CA002400138A patent/CA2400138A1/fr not_active Abandoned
- 2001-03-01 WO PCT/FR2001/000601 patent/WO2001064633A1/fr active IP Right Grant
- 2001-03-01 EE EEP200200486A patent/EE05081B1/xx not_active IP Right Cessation
- 2001-03-01 DE DE60142890T patent/DE60142890D1/de not_active Expired - Lifetime
- 2001-03-01 OA OA1200200269A patent/OA12221A/fr unknown
- 2001-03-01 DK DK01909938.1T patent/DK1263721T3/da active
- 2001-03-02 AR ARP010101025A patent/AR034405A1/es unknown
- 2001-09-07 DZ DZ013311A patent/DZ3311A1/de active
2002
- 2002-08-12 IL IL151209A patent/IL151209A/en not_active IP Right Cessation
- 2002-08-28 ZA ZA200206916A patent/ZA200206916B/en unknown
- 2002-08-28 MA MA26793A patent/MA26879A1/fr unknown
- 2002-08-29 HR HR20020710A patent/HRP20020710A2/hr not_active Application Discontinuation
- 2002-09-02 NO NO20024176A patent/NO324523B1/no not_active IP Right Cessation
- 2002-09-03 BG BG107057A patent/BG107057A/bg unknown
2010
- 2010-10-29 CY CY20101100983T patent/CY1111075T1/el unknown

Also Published As

Publication number	Publication date
EP1263721B1 (de)	2010-08-25
SK12442002A3 (sk)	2003-02-04
BG107057A (bg)	2003-07-31
JP2003525269A (ja)	2003-08-26
DK1263721T3 (da)	2011-01-03
DE60142890D1 (de)	2010-10-07
OA12221A (fr)	2006-05-10
NO20024176L (no)	2002-10-29
NZ521076A (en)	2004-08-27
NO20024176D0 (no)	2002-09-02
PT1263721E (pt)	2010-10-28
AU3752601A (en)	2001-09-12
HUP0300350A2 (hu)	2003-06-28
DZ3311A1 (de)	2001-09-07
SI1263721T1 (sl)	2011-01-31
EE200200486A (et)	2004-02-16
EA200200942A1 (ru)	2003-02-27
FR2805810A1 (fr)	2001-09-07
AR034405A1 (es)	2004-02-25
CN1411440A (zh)	2003-04-16
EE05081B1 (et)	2008-10-15
BR0108894A (pt)	2003-04-29
CN1187325C (zh)	2005-02-02
EA004649B1 (ru)	2004-06-24
TWI294420B (en)	2008-03-11
YU65902A (sh)	2005-09-19
ZA200206916B (en)	2003-07-17
UA72319C2 (en)	2005-02-15
CA2400138A1 (fr)	2001-09-07
IL151209A (en)	2010-05-17
WO2001064633A1 (fr)	2001-09-07
HRP20020710A2 (en)	2005-06-30
AU2001237526B2 (en)	2006-01-05
IL151209A0 (en)	2003-04-10
CY1111075T1 (el)	2015-06-11
EP1263721A1 (de)	2002-12-11
PL365007A1 (en)	2004-12-27
NO324523B1 (no)	2007-11-12
KR20030013375A (ko)	2003-02-14
MA26879A1 (fr)	2004-12-20
MXPA02008346A (es)	2002-12-13
KR100813740B1 (ko)	2008-03-13
ES2351183T3 (es)	2011-02-01
FR2805810B1 (fr)	2002-04-26

Publication	Publication Date	Title
ATE478840T1 (de)	2010-09-15	3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
DE50313653D1 (de)	2011-06-09	Wasserlösliche eisen-kohlenhydrat-komplexe, deren herstellung und diese enthaltende arzneimittel
ATE432919T1 (de)	2009-06-15	Azetidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE188471T1 (de)	2000-01-15	Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
ATE337311T1 (de)	2006-09-15	Heterocyclylalkylpiperidinderivate, deren herstellung und zusammensetzungen, die diese derivate enthalten
DE69928260D1 (de)	2005-12-15	Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen
DE69630145D1 (de)	2003-10-30	Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE233752T1 (de)	2003-03-15	Liponsaürederivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
EE05183B1 (et)	2009-06-15	Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
EE200200357A (et)	2003-10-15	Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
DE60318188D1 (de)	2008-01-31	Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
EE200000468A (et)	2002-04-15	Ühendid, nende kasutamine ja farmatseutiline kompositsioon
EE200100684A (et)	2003-04-15	Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
DE60130834D1 (de)	2007-11-22	Zusammensetzungen gegen schlechte Gerüche, deren Herstellung und Verwendung
DE60045402D1 (de)	2011-01-27	Silylalkylplatin (IV) Verbindungen und deren Herstellung
DE60220258D1 (de)	2007-07-05	Derivate von quinolyl-propyl-piperidine, deren herstellung und die sie enthaltenden zusamensetzungen
DE50003761D1 (de)	2003-10-23	Indeno-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
EE200200281A (et)	2003-06-16	Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks
ATE193533T1 (de)	2000-06-15	Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE60208044D1 (de)	2006-01-19	Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
DE50002417D1 (de)	2003-07-10	3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
DE69706146D1 (de)	2001-09-20	Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69610085D1 (de)	2000-10-05	Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE60012750D1 (de)	2004-09-09	Neue xanthon derivate, deren herstellung und verwendung als arzneimittel
DE60109279D1 (de)	2005-04-14	Pharmazeutische zusammensetzungen mit oligosacchariden und deren herstellung

Legal Events

Date	Code	Title	Description
2011-03-15	UEP	Publication of translation of european patent specification	Ref document number: 1263721 Country of ref document: EP

Date

Code

Title

Description

2011-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1263721

Country of ref document: EP